6,389 reports of this reaction
10.9% of all THALIDOMIDE reports
#1 most reported adverse reaction
DEATH is the #1 most commonly reported adverse reaction for THALIDOMIDE, manufactured by Celgene Corporation. There are 6,389 FDA adverse event reports linking THALIDOMIDE to DEATH. This represents approximately 10.9% of all 58,680 adverse event reports for this drug.
THALIDOMIDE has an overall safety score of 95 out of 100. Patients taking THALIDOMIDE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a frequently reported adverse event for THALIDOMIDE, accounting for a significant proportion of all reports.
In addition to death, the following adverse reactions have been reported for THALIDOMIDE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 6,389 FDA reports for THALIDOMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 10.9% of all adverse event reports for THALIDOMIDE, making it one of the most commonly reported side effect.
If you experience death while taking THALIDOMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.